EIKN
Income statement / Annual
Last year (2025), Eikon Therapeutics Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Eikon Therapeutics Inc.'s net income was -$324.25 M.
See Eikon Therapeutics Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
| Period Ended |
12/31/2025 |
| Operating Revenue |
$0.00 |
| Cost of Revenue |
$24.18 M
|
| Gross Profit |
-$24.18 M
|
| Gross Profit Ratio |
0
|
| Research and Development Expenses |
$250.32 M
|
| General & Administrative Expenses |
$88.63 M
|
| Selling & Marketing Expenses |
$0.00
|
| Selling, General & Administrative Expenses |
$88.63 M
|
| Other Expenses |
-$24.18 M
|
| Operating Expenses |
$314.77 M
|
| Cost And Expenses |
$338.95 M
|
| Interest Income |
$15.57 M
|
| Interest Expense |
$837.00 K
|
| Depreciation & Amortization |
$24.18 M
|
| EBITDA |
-$299.24 M |
| EBITDA Ratio |
0
|
| Operating Income Ratio |
0
|
| Total Other Income/Expenses Net |
$14.70 M
|
| Income Before Tax |
-$324.25 M
|
| Income Before Tax Ratio |
0
|
| Income Tax Expense |
$0.00
|
| Net Income |
-$324.25 M
|
| Net Income Ratio |
0
|
| EPS |
-6.16 |
| EPS Diluted |
-6.16 |
| Weighted Average Shares Out |
$54.14 M
|
| Weighted Average Shares Out Diluted |
$54.14 M
|
| Link |
|
